An interventional study of "VINA STEAM" (Skills to Empower Affirmative Men) in Bisexuality, Homosexuality and HIV Infections, sponsored by Florida State University. Completed at 1 site in Vietnam. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-06.
Sponsored by Florida State University · Not applicable, Interventional, and Treatment
Participants are Vietnamese national. Over the course of the study activities, approximately 184 self-identified Vietnamese national gay and bisexual men ages 18 and above living in HCMC, Viet Nam, as well as 10 key informants (about 5 females) ages 18 and above will participate in the study.
The mixed-method study will involve: (1) preparation stage; (2) formative stage, where qualitative data from Vietnamese GBM and key informants will inform the adaptation of the ESTEEM package; (3) feasibility test, where the adapted intervention will be piloted-test in a small sample (4 small group, N = 24) of GBM and further adjusted on the pilot-test results; and (4) small-scale efficacy test of the adjusted intervention using a randomized waitlist controlled design in a cohort of 120 GBM, where they will be randomly assigned to either the immediate intervention (6 groups) or a waitlist arm (6 groups) with 10 men per groups. During the preparation stage, the investigators will obtain ethical approval from the Florida State University's Institutional Review Board. The investigators will identify and hire staff knowledgeable about the local socio-cultural context pertaining to GBM, fluent in Vietnamese, and familiar with research-oriented studies. All personnel and individual contacting with the study on human participants will be trained on human subject protection. During the qualitative formative stage, the investigators will conduct individual interviews (N = 15) of GBM community representatives, focus group (4 group, N = 25) with GBN community representative and individual interviews (N = 10) of key informants. Key informants (e.g., outreach workers, counselors, consultant, psychologists, program managers) will consist of adults with experience working with GBM in the areas of mental or sexual health, stigma, and/or legal protection. Interviews and focus groups will be audio-recorded. The investigators will intersperse key informant interviews, individual interviews, and focus groups with GBM and the process of ESTEEM adaptation in an iterative manner. For the feasibility test stage, the investigators will recruit 24 GBM to pilot test the adapted intervention in small groups (N = 6 per group) setting to meet once weekly for a period of 8 week. During the intervention, qualitative data will be collected via baseline and endline surveys. Qualitative data will be collected from individual interviews after each individual session in addition to ta final individual and 4 focus groups after completion of all sessions in the intervention. These data will be used to revise the intervention as needed for the small-scale efficacy stage. Audio-recordings of interviews and focus groups from the formative and feasibility test stages will be transcribed verbatim and analyzed in MaxQDA software using thematic analysis. Data from interviews and focus groups will be complemented by information from peer facilitators' oral feedback and participants' open-ended questionnaires.
Qualitative data analysis will be guided by the intervention feasibility domains --acceptability, demand, implementation, practicality, adaptation, integration, and expansion. Due to the small sample size (N = 24) in the feasibility test no inferential statistical analysis of quantitative data will be performed. The investigators will only determine the direction of changes in the primary outcomes and assess effect sizes. For the small-scale efficacy stage, the investigators will enroll and assign 120 consented participants to 12 small groups and with 10 individuals in each group. Then the investigators will randomize the small groups into the immediate intervention and waitlist arms (6 groups in each arm). All participants will complete 3 waves of data collection: baseline, 3-month follow-up, and 6-month follow-up. Power calculations (using PROC POWRR in SAS 9.4 and assuming an intra-cluster correlation of 10%) demonstrates that a sample size of 120 is sufficiently large to detect medium effect size of d = 0.477 via a one-sided independent t-test. The investigators will include all randomized participants into the analysis using an intent-to-treat approach. The investigators will use mixed models with appropriate distribution and link functions based on endpoint variable properties along with repeated measures approach to account for within individual and group correction.
28 studies on the registry are indexed under Homosexuality; 6 are open to participants now.
This study's enrollment of 167 is below the median of 288 across 25 interventional studies indexed under Homosexuality.
Browse Homosexuality studies →Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants immediately enter the intervention upon enrollment
Behavioral: "VINA STEAM" (Skills to Empower Affirmative Men)
Participants enter a waitlist for 4-weeks prior to participating in the intervention
Behavioral: "VINA STEAM" (Skills to Empower Affirmative Men)
The investigators propose and pilot test a community-based, peer-driven minority stress as well as HIV-stigma reduction program in small group of GBM in Ho Chi Minh City, Viet Nam.
Audit-C
Alcohol Use Disorders Identification Test Min Score: 0 Max Score: 12 Higher score correlates with worse outcome
Time frame: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)
Illicit Drug Use
Any illicit drug use and count of illicit drug use by intervention arm and time
Time frame: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)
Condom Use
Condom use episodes with main partner in last 3 months
Time frame: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)
HIV Testing
HIV testing results (ever) Measures number of participants who have ever been tested for HIV, at least once Administered at T2 timepoint Participants must be HIV-negative to enroll and maintain enrollment in study
Time frame: Over course of participant's lifetime
CES-D
Center for Epidemiological Studies Depression Scale Min Score: 0 Max Score: 60 Higher score correlates with worse outcome
Time frame: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)
ODSIS
Overall Depression Severity and Impairment Scale Min Score: 0 Max Score: 20 Higher score correlates with worse outcome
Time frame: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)
OASIS
Overall Anxiety Severity and Impairment Scale Min Score: 0 Max Score: 20 Higher score correlates with worse outcome
Time frame: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)
194 people assessed for eligibility. 20 did not meet inclusion criteria for attendance. 7 could not be reached despite repeated contact attempts. 167 people were thus enrolled in the study.
| Milestone | Immediate Intervention | Waitlist |
|---|---|---|
| Started | 83 | 84 |
| Completed | 69 | 77 |
| Not completed | 14 | 7 |
| Withdrew: Lost to follow-up | 14 | 7 |
Alcohol Use Disorders Identification Test Min Score: 0 Max Score: 12 Higher score correlates with worse outcome
| score on a scale | T1 Immediate Intervention | T2 Immediate Intervention | T3 Immediate Intervention | T1 Waitlist | T2 Waitlist | T3 Waitlist |
|---|---|---|---|---|---|---|
| Audit-C | 1.75 ± 2 | 1.78 ± 2.78 | 1.78 ± 1.93 | 2.74 ± 2.59 | 3.06 ± 2.58 | 3.25 ± 2.64 |
Any illicit drug use and count of illicit drug use by intervention arm and time
| Participants | T1 Immediate Intervention | T2 Immediate Intervention | T3 Immediate Intervention | T1 Waitlist | T2 Waitlist | T3 Waitlist |
|---|---|---|---|---|---|---|
| Illicit Drug Use | 14 | 10 | 7 | 32 | 22 | 23 |
Condom use episodes with main partner in last 3 months
| Participants | T1 Immediate Intervention | T2 Immediate Intervention | T3 Immediate Intervention | T1 Waitlist | T2 Waitlist | T3 Waitlist |
|---|---|---|---|---|---|---|
| Never | 19 | 18 | 14 | 18 | 16 | 16 |
| <50% | 11 | 8 | 6 | 14 | 16 | 14 |
| >50% | 7 | 4 | 3 | 10 | 10 | 7 |
| Always | 11 | 13 | 11 | 23 | 14 | 14 |
| No anal sex with main partner | 8 | 9 | 11 | 10 | 7 | 3 |
HIV testing results (ever) Measures number of participants who have ever been tested for HIV, at least once Administered at T2 timepoint Participants must be HIV-negative to enroll and maintain enrollment in study
| Participants | T2 Immediate Intervention | T2 Waitlist |
|---|---|---|
| HIV Testing | 52 | 55 |
Center for Epidemiological Studies Depression Scale Min Score: 0 Max Score: 60 Higher score correlates with worse outcome
| score on a scale | T1 Immediate Intervention | T2 Immediate Intervention | T3 Immediate Intervention | T1 Waitlist | T2 Waitlist | T3 Waitlist |
|---|---|---|---|---|---|---|
| CES-D | 19.5 ± 16.2 | 16.3 ± 16.0 | 14.8 ± 15.8 | 13.4 ± 12.6 | 11.1 ± 12.7 | 7.5 ± 11.2 |
Overall Depression Severity and Impairment Scale Min Score: 0 Max Score: 20 Higher score correlates with worse outcome
| score on a scale | T1 Immediate Intervention | T2 Immediate Intervention | T3 Immediate Intervention | T1 Waitlist | T2 Waitlist | T3 Waitlist |
|---|---|---|---|---|---|---|
| ODSIS | 4.5 ± 4.2 | 4.0 ± 4.3 | 3.8 ± 4.1 | 3.8 ± 3.5 | 2.4 ± 3.2 | 3.5 ± 3.9 |
Overall Anxiety Severity and Impairment Scale Min Score: 0 Max Score: 20 Higher score correlates with worse outcome
| score on a scale | T1 Immediate Intervention | T2 Immediate Intervention | T3 Immediate Intervention | T1 Waitlist | T2 Waitlist | T3 Waitlist |
|---|---|---|---|---|---|---|
| OASIS | 4.8 ± 4.5 | 4.5 ± 4.4 | 4.1 ± 4.3 | 4.1 ± 3.9 | 3.2 ± 3.5 | 1.8 ± 2.8 |
Collected over T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 months (SD 0.20). T2Intervention: Mean timing from T1 1.73 months (SD 0.87), T2Waitlist: 2.02 months. (SD 1.04). T3Intervention: Mean timing from T2 5.51 months (SD 0.57), T3Waitlist 3.41 months (SD 0.95).. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Immediate Intervention | 0/83 (0%) | 0/83 (0%) | 0/83 (0%) |
| Waitlist | 0/84 (0%) | 0/84 (0%) | 0/84 (0%) |
| Age, Continuous(years) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| Mean | 25 ± 5.3 | 26.4 ± 5.3 | 25.9 ± 5.3 |
| Sex: Female, Male(Participants) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| Female | 0 | 0 | 0 |
| Male | 69 | 77 | 146 |
| Race/Ethnicity, Customized(Participants) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| Ethnicity — Kinh (Viet) | 64 | 71 | 135 |
| Ethnicity — Other | 5 | 6 | 11 |
| Region of Enrollment(participants) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| Vietnam | 69 | 77 | 146 |
| Sexual Orientation(Participants) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| Homosexual | 60 | 75 | 135 |
| Bisexual | 2 | 0 | 2 |
| Heterosexual | 0 | 0 | 0 |
| Other | 7 | 2 | 9 |
| Marital Status(Participants) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| Single | 47 | 56 | 103 |
| Married | 1 | 2 | 3 |
| Relationship | 20 | 18 | 38 |
| Declined to Answer | 1 | 1 | 2 |
| Education(Participants) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| No school | 0 | 0 | 0 |
| Elementary | 0 | 0 | 0 |
| Junior HS | 1 | 1 | 2 |
| High School | 21 | 26 | 47 |
| Vocational | 1 | 5 | 6 |
| Bachelor | 44 | 43 | 87 |
| Masters/PhD | 2 | 1 | 3 |
| Don't Know | 0 | 0 | 0 |
| Refused | 0 | 1 | 1 |
| Number of Children(Number of children) | Immediate Intervention | Waitlist | Total |
|---|---|---|---|
| Mean | 0.1 ± 1.0 | 0.1 ± 0.6 | 0.1 ± 0.8 |
6 further baseline measures are reported on the registry.
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bisexuality
Florida State University